Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based anti-tumour immunotherapy. [electronic resource]
Producer: 20130805Description: 131-9 p. digitalISSN:- 1365-2249
- Antibodies, Monoclonal, Humanized -- pharmacology
- Antibodies, Monoclonal, Murine-Derived -- pharmacology
- Antibody-Dependent Cell Cytotoxicity -- drug effects
- Antigens, Surface -- metabolism
- Antineoplastic Agents -- pharmacology
- CD3 Complex -- metabolism
- Cell Degranulation -- drug effects
- Cell Line, Tumor
- Cetuximab
- Coculture Techniques
- Cytokines -- blood
- Dipeptides -- pharmacology
- Down-Regulation -- drug effects
- GPI-Linked Proteins -- metabolism
- Humans
- Killer Cells, Natural -- drug effects
- Lymphocyte Activation -- drug effects
- Matrix Metalloproteinase Inhibitors -- pharmacology
- Matrix Metalloproteinases -- physiology
- Phosphorylation -- drug effects
- Protein Processing, Post-Translational -- drug effects
- Receptors, IgG -- metabolism
- Rituximab
- Signal Transduction -- drug effects
- Trastuzumab
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.